Drawing for MEDITERA

USPTO serial 79235507

MEDITERA

Reviewed by CopyMark Law Group

Reg. 5836761Status 706Registered
Filing date
Status date
Registration date
Aug 20, 2019
Examiner
EUBANK, REBECCA A
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with MEDITERA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Yakup Sari

Yakup Sari Sari Law Firm540 N Golden Cir Dr.Santa Ana, CA 92705United States

Goods and services

ClassDescriptionStatusFirst use
010[ Medical, dental, veterinarian and surgical apparatus and instruments, namely, injection needles, surgical thread, ] apparatus for artificial respiration, [ blood pressure measuring apparatus, hearing aids; patient breathing system comprising a breathing circuit, connections to patient, ventilator, scavenger, fresh gas delivery circuit and carbon dioxide absorber; ventilators and anesthesia machines for use in patient care; medical ventilators; ] filters for medical purposes, namely, blood filters, filters for anesthesia; [ air filters for medical ventilators; catheters and parts and fittings therefor; displays, monitors and controllers for medical fluid injectors, namely, computer displays and computer monitors and controllers therefor used in direct association with medical fluid injectors; sanitary masks for medical purposes; oxygen masks for medical use; anesthesia masks; face masks for use by health care providers; textile headgear specially adapted for use with medical ventilator mask interfaces; respiratory masks for artificial respiration; endotracheal tubes; ] infusion setsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 7, 2026INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jan 7, 2026NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Jan 7, 202671AGREGISTERED-SEC.71 ACCEPTED—
Dec 30, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 20, 2025ES71TEAS SECTION 71 RECEIVED—
Aug 20, 2024REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Nov 28, 2022ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Oct 26, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 31, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 27, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 14, 2019XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Dec 14, 2019XXCRGENERIC MADRID TRANSACTION CREATED—
Nov 20, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 20, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 14, 2019GPNXNOTIFICATION PROCESSED BY IB—
Jun 4, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 4, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 15, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 15, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
May 15, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 1, 2019PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 1, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 1, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 30, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 29, 2019ALIEASSIGNED TO LIE—
Apr 24, 2019PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Apr 23, 2019NREVNOTICE OF REVIVAL - MAILED—
Apr 22, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 22, 2019PETGPETITION TO REVIVE-GRANTED—
Apr 22, 2019PROATEAS PETITION TO REVIVE RECEIVED—
Feb 22, 2019MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Feb 22, 2019ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Aug 17, 2018RFNTREFUSAL PROCESSED BY IB—
Jul 24, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 24, 2018RFRRREFUSAL PROCESSED BY MPU—
Jul 10, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 9, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 7, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 3, 2018DOCKASSIGNED TO EXAMINER—
Jul 3, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 30, 2018LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Jun 28, 2018SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance